Evidence map›Paper›PMID 34041573›Full record

ArticleAnalytical and bioanalytical chemistry2021

A point-of-care chemiluminescence immunoassay for pepsinogen I enables large-scale community health screening.

Fangfang Liu, Jingjing Zou, Xiangxiang Luo, Yu Liu, Chunrong Huang, Xiaowei He, Yu Wang

Erratum issuedAbstract readEvaluation Study
PubMed Publisher
In one paragraph

Article in Analytical and bioanalytical chemistry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Fangfang Liu *College of Food Science and Engineering, South China University of Technology, Guangzhou, 510640, China.
Jingjing Zou *College of Food Science and Engineering, South China University of Technology, Guangzhou, 510640, China.
Xiangxiang LuoCollege of Food Science and Engineering, South China University of Technology, Guangzhou, 510640, China.
Yu LiuCollege of Food Science and Engineering, South China University of Technology, Guangzhou, 510640, China.
Chunrong HuangNational & Local United Engineering Lab of Rapid Diagnostic Test, Guangzhou Wondfo Biotech Co., Ltd., Guangzhou, 5l0663, China.
Xiaowei HeCollege of Food Science and Engineering, South China University of Technology, Guangzhou, 510640, China. fexwhe@scut.edu.cn.
Yu WangDepartment of Laboratory Medicine, Guangzhou First People's Hospital, the Second Affiliated Hospital of South China University of Technology, Guangzhou, 510180, China. wyhgn3344@163.com.
South China University of Technology · CN

Funding

Program of Guangdong Province R & D in key areas 2020B1111160004Program of Guangzhou Science & Technology 201802010030, 2201902010003Science and Technology Program of Guangdong Province 2021B1212050016the Postdoctoral Scientific Research Project of Guangzhou BHSKY20200301
6 · The paper itself

Abstract

Pepsinogen I (PGI) can reflect the morphology and function of the gastric mucosa. Accordingly, the large-scale community health screening of PGI can dramatically increase the early diagnosis rate of gastric cancer. However, PGI testing can only be carried out in comprehensive hospitals and health examination centers. To ameliorate this issue, a point-of-care chemiluminescent immunoassay for PGI was developed in a fully automated miniaturized instrument. This instrument was especially developed for health check-ups in the grassroots communities; its volume of which is only 0.18 m

Indexed as

Point-of-Care TestingEarly Detection of CancerHumansImmunoassayLimit of DetectionLuminescent MeasurementsPepsinogen AStomach NeoplasmsPepsinogen AChemiluminescence immunoassayCommunity health screeningPepsinogen IPoint-of-care

Identifiers

PMID34041573
OpenAlexW3164070582

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.